- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cholesterol and its association with muscle weakness in critical illness ; volume:25 ; number:1 ; day:17 ; month:8 ; year:2021 ; pages:1-2 ; date:12.2021
Critical care ; 25, Heft 1 (17.8.2021), 1-2, 12.2021
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-021-03722-2
- URN
-
urn:nbn:de:101:1-2021110521000128267901
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hofmaenner, Daniel A.
- Kleyman, Anna
- Singer, Mervyn
- SpringerLink (Online service)
Ähnliche Objekte (12)
Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
Impaired Ca2+ release contributes to muscle weakness in a rat model of critical illness myopathy
Mitochondrial function in skeletal muscle of patients with protracted critical illness and ICU-acquired weakness
Glucocorticoid treatment increases cholesterol availability during critical illness: effect on adrenal and muscle function
Acute Nontraumatic Muscle Weakness
Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes
Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?
Publisher Correction to: Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long‑term outcomes
Respiratory muscle weakness in facioscapulohumeral muscular dystrophy
Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness
Expanding the scope of prehabilitation: reducing critical illness weakness across elective surgical patients scheduled for postoperative ICU care
Understanding and combating age-related muscle weakness: MYOAGE challenge
Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
Impaired Ca2+ release contributes to muscle weakness in a rat model of critical illness myopathy
Mitochondrial function in skeletal muscle of patients with protracted critical illness and ICU-acquired weakness
Glucocorticoid treatment increases cholesterol availability during critical illness: effect on adrenal and muscle function
Acute Nontraumatic Muscle Weakness
Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes
Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?
Publisher Correction to: Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long‑term outcomes
Respiratory muscle weakness in facioscapulohumeral muscular dystrophy
Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness
Expanding the scope of prehabilitation: reducing critical illness weakness across elective surgical patients scheduled for postoperative ICU care
Understanding and combating age-related muscle weakness: MYOAGE challenge
Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
Impaired Ca2+ release contributes to muscle weakness in a rat model of critical illness myopathy
Mitochondrial function in skeletal muscle of patients with protracted critical illness and ICU-acquired weakness
Glucocorticoid treatment increases cholesterol availability during critical illness: effect on adrenal and muscle function
Acute Nontraumatic Muscle Weakness
Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes
Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?
Publisher Correction to: Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long‑term outcomes
Respiratory muscle weakness in facioscapulohumeral muscular dystrophy
Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness
Expanding the scope of prehabilitation: reducing critical illness weakness across elective surgical patients scheduled for postoperative ICU care